IS5719A - Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni - Google Patents

Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni

Info

Publication number
IS5719A
IS5719A IS5719A IS5719A IS5719A IS 5719 A IS5719 A IS 5719A IS 5719 A IS5719 A IS 5719A IS 5719 A IS5719 A IS 5719A IS 5719 A IS5719 A IS 5719A
Authority
IS
Iceland
Prior art keywords
estrogen receptor
parathyroid hormone
receptor modulator
selective estrogen
treatment combinations
Prior art date
Application number
IS5719A
Other languages
English (en)
Inventor
Zhu Ke Hua
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5719A publication Critical patent/IS5719A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
IS5719A 1998-06-16 2000-11-21 Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni IS5719A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16
PCT/IB1999/000949 WO1999065482A1 (en) 1998-06-16 1999-05-26 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Publications (1)

Publication Number Publication Date
IS5719A true IS5719A (is) 2000-11-21

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5719A IS5719A (is) 1998-06-16 2000-11-21 Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni

Country Status (34)

Country Link
US (1) US6132774A (is)
EP (1) EP1094808A1 (is)
JP (1) JP2002518323A (is)
KR (1) KR20010052818A (is)
CN (1) CN1305373A (is)
AP (1) AP9901580A0 (is)
AR (1) AR018867A1 (is)
AU (1) AU3725999A (is)
BG (1) BG105125A (is)
BR (1) BR9911228A (is)
CA (1) CA2335078A1 (is)
CO (1) CO5070584A1 (is)
EA (1) EA200001199A1 (is)
GT (1) GT199900066A (is)
HN (1) HN1999000063A (is)
HR (1) HRP20000858A2 (is)
HU (1) HUP0102759A3 (is)
ID (1) ID26873A (is)
IL (1) IL139588A0 (is)
IS (1) IS5719A (is)
MA (1) MA26649A1 (is)
NO (1) NO20006313L (is)
NZ (1) NZ508039A (is)
OA (1) OA11566A (is)
PA (1) PA8471201A1 (is)
PE (1) PE20000644A1 (is)
PL (1) PL344982A1 (is)
SK (1) SK18922000A3 (is)
TN (1) TNSN99119A1 (is)
TR (1) TR200003567T2 (is)
UA (1) UA60367C2 (is)
WO (1) WO1999065482A1 (is)
YU (1) YU75800A (is)
ZA (1) ZA993972B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
WO2006056845A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
KR20010052818A (ko) 2001-06-25
CO5070584A1 (es) 2001-08-28
PL344982A1 (en) 2001-11-19
NO20006313D0 (no) 2000-12-12
BR9911228A (pt) 2001-02-13
NZ508039A (en) 2003-03-28
US6132774A (en) 2000-10-17
AU3725999A (en) 2000-01-05
ZA993972B (en) 2000-12-15
CA2335078A1 (en) 1999-12-23
AP9901580A0 (en) 1999-06-30
BG105125A (en) 2001-11-30
HUP0102759A2 (hu) 2002-03-28
HN1999000063A (es) 2000-01-12
WO1999065482A1 (en) 1999-12-23
IL139588A0 (en) 2002-02-10
UA60367C2 (uk) 2003-10-15
TR200003567T2 (tr) 2001-06-21
NO20006313L (no) 2000-12-12
HRP20000858A2 (en) 2001-10-31
EP1094808A1 (en) 2001-05-02
EA200001199A1 (ru) 2001-04-23
OA11566A (en) 2004-05-26
MA26649A1 (fr) 2004-12-20
CN1305373A (zh) 2001-07-25
GT199900066A (es) 2000-10-31
PA8471201A1 (es) 2000-09-29
AR018867A1 (es) 2001-12-12
PE20000644A1 (es) 2000-08-02
YU75800A (sh) 2003-12-31
ID26873A (id) 2001-02-15
JP2002518323A (ja) 2002-06-25
TNSN99119A1 (fr) 2005-11-10
HUP0102759A3 (en) 2002-12-28
SK18922000A3 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
GB2361878B (en) Bone cement mixer and method
IS5719A (is) Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni
NO995845L (no) Ikke-steroide, (hetero) syklisk-substituerte acylanilider med blandet gestagen- og androgen virkning
SG96605A1 (en) Substrate holding apparatus and exposure apparatus including substrate holding apparatus
DE69817549D1 (de) Satellitenkommunikationszwischenverstärker und wiederübertragungsverfahren
IL204486A0 (en) Selective androgen receptor modulators and methods of uses thereof
DE69826829D1 (de) Digitales kommunikationsgerät und mischer
NO20025143D0 (no) Modulatorer av reseptorer for paratyroid hormon og paratyriod hormonforbundet protein
IL136037A0 (en) Exposure apparatus, apparatus for manufacturing devices, and method of manufacturing exposure apparatuses
AU1179200A (en) Exposure method and device
HUP0102045A3 (en) Device and method for controlled parallel operation of direct current converters
EP1185937A4 (en) METHOD FOR PROVIDING NETWORK SERVICES AND CORRESPONDING SYSTEM
AU2002235130A8 (en) Method and system for providing communications services
AU2076099A (en) Exposure method and device
SG83810A1 (en) Exposure method and exposure apparatus
NO993680D0 (no) Forankringsanordning og fremgangsmåte
HK1032553A1 (en) Mixing method and mixing device
DE60030644D1 (de) Maskendruckverfahren und Maskendruckvorrichtung
ATE215819T1 (de) Transdermales therapeutisches system, enthaltend hormone und kristallisationsinhibitoren
AU1365102A (en) Pour-on application method and devices
FI980472A (fi) Latausmenetelmä ja -järjestely
NO20015795D0 (no) Digitalt satellitt-kommunikasjonssystem og -fremgangsmåte
EP1049107A4 (en) METHOD AND DEVICE FOR ACTIVATING A SUBSTANCE
DK0956022T3 (da) Hormonpræparat indeholdende en østrogenforbindelse og en progestativ forbindelse
AU2828900A (en) Exposure method, exposure device, exposure system, mask and device manufacturingmethod